期刊文献+

干细胞因子SOX2在肺癌中的表达及意义 被引量:7

Expression and significance of stem-cell-abundant protein SOX2 in lung cancer
下载PDF
导出
摘要 目的通过检测肺癌组织中干细胞因子SOX2的表达水平,了解其表达与肺癌病理特征之间的关系。方法应用免疫组织化学方法检测112例肺癌患者术后癌组织标本中SOX2蛋白的表达水平,探讨其与肺癌临床病理特征及发生发展的关系。结果 SOX2蛋白在肺癌组织中的阳性表达率为95.54%,在正常肺组织中无表达。其表达水平与肺癌的分化程度、有无淋巴结转移有关,而与患者的性别、年龄、组织类型等无关。结论 SOX2将可能成为肺癌临床诊断和病理分型的重要检测因子。 Objective To observe the expression and significance of stem-cell-abundant protein SOX2 in lung cancer.Method Immunohistochemistry analysis was used to detect the level of SOX2 expression in 112 patients with lung cancer,and to discuss the relationship between SOX2 expression and the clinical and pathologic data of lung cancer.Result SOX2 expression positive rate was 95.54% in lung cancer tissue,which was correlated with differentiation grade and whether lymph node metastasis,not correlated with sex,age,type of organization,et al.Conclusion SOX2 maybe become an important detection factor of the diagnosis and classification of lung cancer.
出处 《山东医药》 CAS 北大核心 2011年第28期12-14,118,共4页 Shandong Medical Journal
基金 辽宁省教育厅科研项目计划(2009A477)
关键词 肺肿瘤 SOX2 免疫组织化学 lung neoplasms SOX2 immunohistochemistry
  • 相关文献

参考文献11

  • 1Socinski MA, Stinchcombe TE. Duration of first-line chemotherapy in advanced non-small-cell lung cancer: less is more in the era of effective subsequent therapies [ J]. J Clin Oncol, 2007,25 (33) : 5155-5157.
  • 2Huntly BJ, GiUiland DG. Cancer biology: summing up cancer stem ceils [J]. Nature, 2005,435(7046) :1169-1170.
  • 3Zhang S, Balch C, Chan MW, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors [ J]. Cancer Res, 2008,68 ( 11 ) :4311-4320.
  • 4Takaishi S, Okumura T, Tu SP, et al. Identification of gastric cancer stem cells using the cell surface marker CD44 [ J]. Stem Cells, 2009,27 ( 5 ) : 1006 1020.
  • 5Pan J, Zhang Q,Wang Y, et al. 26S proteasome activity is downregulated in lung cancer stem-like cglls propagated in vitro [ J ]. PLoS One, 2010,5(10) :e13298.
  • 6Weiss MA. Floppy SOX: mutual induced fit in hmg (high-mobility group) box-DNA recognition [J]. Mol Endocfinol, 2001,15(3) : 353-362.
  • 7Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells [J]. Nat Rev Mol Cell Biol, 2005,6( 11 ) :872-884.
  • 8Iki K, Pour PM. Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model [ J ]. Pancreaf01ogy, 2006,6 (4) : 406-413.
  • 9Sanada Y, Yoshida K, Ohara M, et al. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components [ J ]. Pancreas,2006,32i2):164-170.
  • 10Tsukamoto T, Mizoshita T, Mihara M, et al. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes [ J ]. Histopathology, 2005,46 (6) :649-658.

同被引文献43

  • 1Takebe N, Ivy SP. Controversies in cancer stem cells targeting embryonic signaling pathways[J]. Clin Cancer Res, 2010,16(12):3106- 3112.
  • 2Takaishi S,()kunmra T, Tu S,el al. Identification of gastric cancer stem cells using the ceil surface marker CI)44[J]. Stem (_?ells, 2009,27 (5) :1006-1020.
  • 3Sanada Y, Yoshida K, ()hara M, el al. Histopathologlc evMuation of stepwisc lrogression of tmncreat[c carcinoma with immunohistoehemical analysis of gastric epitheliat transcription factor SOX2 : comparison of expression patterns between invasive components and cancerous or nonncoplaslic intraductal componenls[J]. Pancreas, 2006, 32(2) : 184 -170.
  • 4J emal A,Siegel R,Xu J, et al. Cancer statistics[-J]. CA Cancer J Clin, 2010,60,277.
  • 5Guhbay J,Collignon J,Koopman P,et al. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes[J]. Nature, 1990,346:245.
  • 6Wang Q, He W,Lu C,et al. Oct3/4 and sox2 are significantly as- sociated with an unfavorable clinical outcome in human esophage- al squamous cell carcinoma [-J]. Anticancer Res, 2009, 29 ( 4 ) : 1233.
  • 7Soullier S, Jay P, Poulat F, et al. Diversification pattern of the HMG and SOX family members during evolution [J]. J Mol Evo1,1999,48(5) :517.
  • 8Bowles J,SehePers G, KooPman P, et al. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators[J]. Dev Biol, 2000,227 (2) : 239.
  • 9Chen L C, Vural B, Ustaner Z, et al. Immunoreactivity to SOX 1 <2 ,-3 and ZIC2 antigens and correlation to survival in small cell lung cancer (SCLC) [J]. J Clin Oncol , 2004, ( 14)22 : 7159.
  • 10Lengerke C,Fehm T,Kuilh R,et al. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinorna[J]. BMC Cancer,2011,11:42.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部